How controlled release technology can aid gene delivery

Bibliography

• Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Gen 2011;12:316–28
   PubMed Web of Science ®Google Scholar
• Vllasaliu D, Fowler R, Stolnik S. PEGylated nanomedicines: recent progress and remaining concerns. Expert Opin Drug Deliv 2014;11:139–54
   PubMed Web of Science ®Google Scholar
• Pachar JV, Cameron JM. Scanning electron microscopy: application in the identification of diatoms in cases of drowning. J Foren Sci 1992;37:860–6
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang N. Nanoparticles in gene therapy principles, prospects, and challenges. Prog Mol Biol Transl Sci 2011;104:509–62
   PubMed Web of Science ®Google Scholar
• Itaka K, Kataoka K. Progress and prospects of polyplex nanomicelles for plasmid DNA delivery. Curr Gene Ther 2011;11:457–65
   PubMed Web of Science ®Google Scholar
• Singha K, Namgung R, Kim WJ. Polymers in small-interfering RNA delivery. Nucleic Acid Ther 2011;21:133–47
   PubMed Web of Science ®Google Scholar
• Xiong F, Mi Z, Gu N. Cationic liposomes as gene delivery system: transfection efficiency and new application. Pharmazie 2011;66:158–64
   PubMed Web of Science ®Google Scholar
• Tros de Ilarduya C, Sun Y, Duzgunes N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 2010;40:159–70
   PubMed Web of Science ®Google Scholar
• Ewert KK, Zidovska A, Ahmad A, et al. Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA. Top Curr Chem 2010;296:191–226
   PubMed Web of Science ®Google Scholar
• Yameen B, Choi WI, Vilos C, et al. Insight into nanoparticle cellular uptake and intracellular targeting. J Cont Rel 2014;190:485–99
   PubMed Web of Science ®Google Scholar
• Yu W, Zhang N, Li C. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery. Curr Pharm Des 2009;15:3826–36
   PubMed Web of Science ®Google Scholar
• Kim TH, Jiang HL, Nah JW, et al. Receptor-mediated gene delivery using chemically modified chitosan. Biomed Mat 2007;2:S95–100
   PubMed Web of Science ®Google Scholar
• Gaidamakova EK, Backer MV, Backer JM. Molecular vehicle for target-mediated delivery of therapeutics and diagnostics. J Control Release 2001;74:341–7
   PubMed Web of Science ®Google Scholar
• Nakase I, Kobayashi S, Futaki S. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules. Biopolymers 2010;94:763–70
   PubMed Web of Science ®Google Scholar
• Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002;9:1647–52
   PubMed Web of Science ®Google Scholar
• Tachibana R, Harashima H, Shinohara Y, et al. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv Drug Deliv Rev 2001;52:219–26
   PubMed Web of Science ®Google Scholar
• Nakanishi H, Higuchi Y, Kawakami S, et al. Development and therapeutic application of transposon-based vectors. Yakugaku Zasshi 2009;129:1433–43
   PubMed Web of Science ®Google Scholar
• Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176:1125–35
   PubMed Web of Science ®Google Scholar
• Jimenez A, Davies J. Expression of a transposable antibiotic resistance element in Saccharomyces. Nature 1980;287:869–71
   PubMed Web of Science ®Google Scholar
• Kajihara M, Sugie T, Mizuno M, et al. Development of new drug delivery system for protein drugs using silicone (I). J Cont Rel 2000;66:49–61
   PubMed Web of Science ®Google Scholar
• Thakral S, Thakral NK, Majumdar DK. Eudragit: a technology evaluation. Expert Opin Drug Deliv 2013;10:131–49
   PubMed Web of Science ®Google Scholar
• Armentano I, Fortunati E, Mattioli S, et al. Biodegradable composite scaffolds: a strategy to modulate stem cell behaviour. Recent Pat Drug Deliv Formul 2013;7:9–17
   PubMedGoogle Scholar
• Liu X, Holzwarth JM, Ma PX. Functionalized synthetic biodegradable polymer scaffolds for tissue engineering. Macromol Biosci 2012;12:911–19
   PubMed Web of Science ®Google Scholar
• Buwalda SJ, Boere KW, Dijkstra PJ, et al. Hydrogels in a historical perspective: from simple networks to smart materials. J Cont Rel 2014;190:254–73
   PubMed Web of Science ®Google Scholar
• Ito T, Otsuka M. Application of calcium phosphate as a controlled-release device. Biol Pharm Bull 2013;36:1676–82
   PubMed Web of Science ®Google Scholar
• Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res 1992;9:283–90
   PubMed Web of Science ®Google Scholar
• Langer RS, Peppas NA. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981;2:201–14
   PubMed Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, et al. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. Int J Pharma 2011;415:34–52
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 2013;30:369–409
   PubMed Web of Science ®Google Scholar
• Ozeki M, Tabata Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 2005;16:549–61
   PubMed Web of Science ®Google Scholar
• Young S, Wong M, Tabata Y, et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Cont Rel 2005;109:256–74
   PubMed Web of Science ®Google Scholar
• Tabata Y. Biomaterial technology for tissue engineering applications. J R Soc Interface 2009;6(Suppl 3):S311–24
   PubMed Web of Science ®Google Scholar
• Marui A, Tabata Y, Kojima S, et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 2007;71:1181–6
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kumakawa K, Usami S, et al. A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment. BMC Med 2014;12:219
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Sakamoto T, Hiraumi H, et al. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med 2010;8:76
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Tanaka R, Okada K, et al. The Effect of Control-released Basic Fibroblast Growth Factor in Wound Healing: Histological Analyses and Clinical Application. Plast Reconst Surg Global Open 2013;1:e44
   PubMedGoogle Scholar
• Hato N, Nota J, Komobuchi H, et al. Facial nerve decompression surgery using bFGF-impregnated biodegradable gelatin hydrogel in patients with Bell palsy. Otolaryngol Head Neck Surg 2012;146:641–6
   PubMed Web of Science ®Google Scholar
• Egilmez NK, Jong YS, Sabel MS, et al. In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res 2000;60:3832–7
   PubMed Web of Science ®Google Scholar
• Mathiowitz E, Jacob JS, Jong YS, et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 1997;386:410–14
   PubMed Web of Science ®Google Scholar
• Nguyen DN, Raghavan SS, Tashima LM, et al. Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine). Biomaterials 2008;29:2783–93
   PubMed Web of Science ®Google Scholar
• Wang D, Robinson DR, Kwon GS, et al. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Cont Rel 1999;57:9–18
   PubMed Web of Science ®Google Scholar
• Tinsley-Bown AM, Fretwell R, Dowsett AB, et al. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Cont Rel 2000;66:229–41
   PubMed Web of Science ®Google Scholar
• Cohen H, Levy RJ, Gao J, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 2000;7:1896–905
   PubMed Web of Science ®Google Scholar
• Stern M, Ulrich K, Geddes DM, et al. Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther 2003;10:1282–8
   PubMed Web of Science ®Google Scholar
• Chun KW, Cho KC, Kim SH, et al. Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method. J Biomater Sci Polym Ed 2004;15:1341–53
   PubMed Web of Science ®Google Scholar
• Diez S, Tros de Ilarduya C. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharma Biopharmaceut 2006;63:188–97
   PubMed Web of Science ®Google Scholar
• Intra J, Salem AK. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells. J Drug Target 2011;19:393–408
   PubMed Web of Science ®Google Scholar
• Chen M, Gao S, Dong M, et al. Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 2012;6:4835–44
   PubMed Web of Science ®Google Scholar
• Lowry N, Goderie SK, Lederman P, et al. The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice. Biomaterials 2012;33:2892–901
   PubMed Web of Science ®Google Scholar
• Needham CJ, Shah SR, Mountziaris PM, et al. Modulation of polyplex release from biodegradable microparticles through poly(ethylenimine) modification and varying loading concentration. Pharm Res 2014;31:77–85
   PubMed Web of Science ®Google Scholar
• Qiao C, Zhang K, Jin H, et al. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int J Nanomedicine 2013;8:2985–95
   PubMed Web of Science ®Google Scholar
• Li Z, Huang L. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline). J Cont Rel 2004;98:437–46
   PubMed Web of Science ®Google Scholar
• Zhang XQ, Tang H, Hoshi R, et al. Sustained transgene expression via citric acid-based polyester elastomers. Biomaterials 2009;30:2632–41
   PubMed Web of Science ®Google Scholar
• Kasper FK, Seidlits SK, Tang A, et al. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J Cont Rel 2005;104:521–39
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang PC, Mao HQ, et al. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 2002;9:1254–61
   PubMed Web of Science ®Google Scholar
• Li Z, Yin H, Zhang Z, et al. Supramolecular anchoring of DNA polyplexes in cyclodextrin-based polypseudorotaxane hydrogels for sustained gene delivery. Biomacromolecules 2012;13:3162–72
   PubMed Web of Science ®Google Scholar
• Kong HJ, Kim ES, Huang YC, et al. Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 2008;25:1230–8
   PubMed Web of Science ®Google Scholar
• Gustafson J, Greish K, Frandsen J, et al. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Cont Rel 2009;140:256–61
   PubMed Web of Science ®Google Scholar
• Ochiya T, Nagahara S, Sano A, et al. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Cur Gene Ther 2001;1:31–52
   PubMedGoogle Scholar
• Ochiya T, Takahama Y, Nagahara S, et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med 1999;5:707–10
   PubMed Web of Science ®Google Scholar
• Sano A, Maeda M, Nagahara S, et al. Atelocollagen for protein and gene delivery. Adv Drug Deliv Rev 2003;55:1651–77
   PubMed Web of Science ®Google Scholar
• Fukunaka Y, Iwanaga K, Morimoto K, et al. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release 2002;80:333–43
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, et al. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm Res 2004;21:1109–18
   PubMed Web of Science ®Google Scholar
• Achille C, Sundaresh S, Chu B, et al. Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells. PLoS ONE 2012;7:e52356
   PubMed Web of Science ®Google Scholar
• Tomioka A, Tanaka M, De Velasco MA, et al. Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther 2008;7:1864–70
   PubMed Web of Science ®Google Scholar
• Xu Q, Leong J, Chua QY, et al. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials 2013;34:5149–62
   PubMed Web of Science ®Google Scholar
• Bourquin C, Wurzenberger C, Heidegger S, et al. Delivery of immunostimulatory RNA oligonucleotides by gelatin nanoparticles triggers an efficient antitumoral response. J Immunother 2010;33:935–44
   PubMed Web of Science ®Google Scholar
• Keegan ME, Saltzman WM. Surface-modified biodegradable microspheres for DNA vaccine delivery. Methods Mol Med 2006;127:107–13
   PubMedGoogle Scholar
• Singh M, Briones M, Ott G, et al. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Nat Acad Sci USA 2000;97:811–16
   PubMed Web of Science ®Google Scholar
• Putney SD, Brown J, Cucco C, et al. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide. Antisense Nucleic Acid Drug Dev 1999;9:451–8
   PubMedGoogle Scholar
• Kushibiki T, Matsumoto K, Nakamura T, et al. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 2004;11:1205–14
   PubMed Web of Science ®Google Scholar
• Matsumoto G, Omi Y, Lee U, et al. NK4 gene therapy combined with cisplatin inhibits tumour growth and metastasis of squamous cell carcinoma. Anti Res 2011;31:105–11
   Google Scholar
• Matsumoto G, Kushibiki T, Kinoshita Y, et al. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci 2006;97:313–21
   PubMed Web of Science ®Google Scholar
• Chew SA, Kretlow JD, Spicer PP, et al. Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model. Tissue engineering Part A 2011;17:751–63
   PubMed Web of Science ®Google Scholar
• Kasahara H, Tanaka E, Fukuyama N, et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J Am Coll Cardiol 2003;41:1056–62
   PubMed Web of Science ®Google Scholar
• Aoyama T, Yamamoto S, Kanematsu A, et al. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Tissue Engg 2003;9:1289–99
   PubMedGoogle Scholar
• Lin X, Jo H, Ishii TM, et al. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J 2009;73:2315–21
   PubMed Web of Science ®Google Scholar
• Wu TH, Hsu SH, Chang MH, et al. Reducing scar formation by regulation of IL-1 and MMP-9 expression by using sustained release of prednisolone-loaded PDLL microspheres in a murine wound model. J Biomed Mater Res Part A 2013;101:1165–72
   PubMed Web of Science ®Google Scholar
• Xia Z, Abe K, Furusu A, et al. Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am J Nephrol 2008;28:34–46
   PubMed Web of Science ®Google Scholar
• Zhong H, Matsui O, Xu K, et al. Gene transduction into aortic wall using plasmid-loaded cationized gelatin hydrogel-coated polyester stent graft. J Vasc Surg 2009;50:1433–43
   PubMed Web of Science ®Google Scholar
• Nakamura M, Jo J, Tabata Y, et al. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. Am J Pathol 2008;172:650–8
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Drug delivery systems for antitumor activation of macrophages. Crit Rev Ther Drug Carrier Syst 1990;7:121–48
   PubMed Web of Science ®Google Scholar
• Nagaya N, Kangawa K, Kanda M, et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003;108:889–95
   PubMed Web of Science ®Google Scholar
• Obata Y, Nishino T, Kushibiki T, et al. HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice. Acta Biomater 2012;8:2688–96
   PubMed Web of Science ®Google Scholar
• Doi N, Jo JI, Tabata Y. Preparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNA. J Biomater Sci Polym Ed 2011. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Nakamura Y, Jo J, et al. Gelatin nanospheres incorporating siRNA for controlled intracellular release. Biomaterials 2012;33:9097–104
   PubMed Web of Science ®Google Scholar
• Okazaki A, Jo JI, Tabata Y. A. reverse transfection technology to genetically engineer adult stem cells. Tissue Eng 2006;13(2):245–51
   Google Scholar
• Kido Y, Jo J, Tabata Y. A gene transfection for rat mesenchymal stromal cells in biodegradable gelatin scaffolds containing cationized polysaccharides. Biomaterials 2011;32:919–25
   PubMed Web of Science ®Google Scholar
• Hama S, Akita H, Ito R, et al. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 2006;13:786–94
   PubMed Web of Science ®Google Scholar
• Liedl T, Dietz H, Yurke B, et al. Controlled trapping and release of quantum dots in a DNA-switchable hydrogel. Small 2007;3:1688–93
   PubMed Web of Science ®Google Scholar
• Bhatia D, Mehtab S, Krishnan R, et al. Icosahedral DNA nanocapsules by modular assembly. Angew Chem Int Ed Engl 2009;48:4134–7
   PubMed Web of Science ®Google Scholar
• Liu J, Du X, Zhang X. Enzyme-inspired controlled release of cucurbit7uril nanovalves by using magnetic mesoporous silica. Chemistry (Easton) 2011;17:810–15
   PubMed Web of Science ®Google Scholar
• Walsh AS, Yin H, Erben CM, et al. DNA cage delivery to mammalian cells. ACS Nano 2011;5:5427–32
   PubMed Web of Science ®Google Scholar
• Sato K, Hosokawa K, Maeda M. Colorimetric biosensors based on DNA-nanoparticle conjugates. Anal Sci 2007;23:17–20
   PubMed Web of Science ®Google Scholar
• Baeissa A, Dave N, Smith BD, et al. DNA-functionalized monolithic hydrogels and gold nanoparticles for colorimetric DNA detection. ACS Appl Mater Interfaces 2010;2:3594–600
   PubMed Web of Science ®Google Scholar
• Jiang FX, Yurke B, Schloss RS, et al. Effect of dynamic stiffness of the substrates on neurite outgrowth by using a DNA-crosslinked hydrogel. Tissue Eng Part A 2010;16:1873–89
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Mizuno Y, Mohri K, et al. Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice. Biomaterials 2011;32:488–94
   PubMed Web of Science ®Google Scholar
• Ela S, Mager I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013;12:347–57
   PubMed Web of Science ®Google Scholar
• Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014;14:195–208
   PubMed Web of Science ®Google Scholar
• Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng 2007;103:389–98
   PubMed Web of Science ®Google Scholar
• Fukuda J, Sakai Y, Nakazawa K. Novel hepatocyte culture system developed using microfabrication and collagen/polyethylene glycol microcontact printing. Biomaterials 2006;27:1061–70
   PubMed Web of Science ®Google Scholar
• Rodriguez-Enriquez S, Gallardo-Perez JC, Aviles-Salas A, et al. Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol 2008;216:189–97
   PubMed Web of Science ®Google Scholar
• Chen DY, Wei HJ, Lin WW, et al. Intramuscular delivery of 3D aggregates of HUVECs and cbMSCs for cellular cardiomyoplasty in rats with myocardial infarction. J Cont Rel 2013;172:419–25
   PubMed Web of Science ®Google Scholar
• Hayashi K, Tabata Y. Preparation of stem cell aggregates with gelatin microspheres to enhance biological functions. Acta Biomat 2011;7:2797–803
   PubMed Web of Science ®Google Scholar
• Tajima S, Tabata Y. Preparation and functional evaluation of cell aggregates incorporating gelatin microspheres with different degradabilities. J Tissue Eng Regen Med 2013;7:801–11
   PubMed Web of Science ®Google Scholar